Supraventricular Tachycardia (AVNRT)

1. Executive Overview: Understanding AVNRT

Atrioventricular Nodal Reentrant Tachycardia (AVNRT) is the most prevalent form of paroxysmal supraventricular tachycardia (PSVT). It is an electrophysiological cardiac arrhythmia characterized by a rapid heart rate originating above the ventricles, specifically within the atrioventricular (AV) node.

Clinically categorized under ICD-10 code I47.1, AVNRT occurs when a reentrant circuit forms within the AV node, leading to a self-sustaining loop of electrical activation. While generally non-life-threatening in patients without structural heart disease, the sudden onset of palpitations, dizziness, and hemodynamic instability can significantly impair quality of life. Understanding the mechanism of this arrhythmia is crucial for effective management and long-term cardiac health.

2. Pathophysiology, Etiology, and Risk Factors

The Mechanism of Reentry

The hallmark of AVNRT is "dual AV nodal physiology." In a healthy heart, electrical impulses travel through the AV node in a uniform fashion. In patients with AVNRT, the AV node contains two distinct functional pathways with different electrophysiological properties:

• The Fast Pathway: Possesses a shorter refractory period but slower conduction velocity.
• The Slow Pathway: Possesses a longer refractory period but faster conduction velocity.

When an atrial premature beat arrives at the AV node while the fast pathway is still refractory (due to its longer refractory period), the impulse is forced down the slow pathway. By the time it reaches the bottom of the node, the fast pathway has recovered, allowing the impulse to travel retrograde back up to the atria. This creates a circular, self-perpetuating loop (reentry), causing the heart to beat rapidly.

Etiology and Triggers

AVNRT is not typically caused by structural heart disease. Instead, it is an inherent electrical "wiring" issue. However, several factors can trigger an episode:
* Catecholaminergic Surge: Stress, intense exercise, or emotional distress.
* Stimulants: Excessive caffeine, nicotine, or alcohol consumption.
* Electrolyte Imbalances: Hypokalemia or hypomagnesemia.
* Medications: Certain over-the-counter decongestants or respiratory stimulants.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of AVNRT is typically characterized by the "paroxysmal" nature of the episodes—they start and stop abruptly.

Common Clinical Manifestations

• Palpitations: A sensation of a "pounding" or "racing" heart, often described as fluttering in the chest or neck.
• Neck Pulsations: Known as the "frog sign," this occurs due to the simultaneous contraction of the atria and ventricles, causing the tricuspid valve to push blood back into the jugular veins.
• Presyncope/Syncope: Lightheadedness or fainting resulting from reduced cardiac output during the tachycardia.
• Dyspnea: Shortness of breath resulting from the rapid rate limiting diastolic filling time.
• Chest Discomfort: Often related to increased myocardial oxygen demand.

Patients often report that the tachycardia begins with a sudden "thump" or premature beat, followed immediately by a sustained, rhythmic rapid heartbeat.

4. Standard Diagnostic Evaluation & Workup

Accurate diagnosis is essential to differentiate AVNRT from other tachycardias such as Atrial Fibrillation or Wolff-Parkinson-White (WPW) syndrome.

Clinical Diagnostic Criteria

1. 12-Lead Electrocardiogram (ECG): During the tachycardia, the ECG typically shows a narrow QRS complex (tachycardia with QRS < 120ms). P-waves are often absent or buried within the QRS complex. If visible, they may appear as a "pseudo-r'" in lead V1.
2. Holter/Event Monitoring: For patients with infrequent episodes, 24-hour Holter monitors or 30-day event recorders are used to capture the arrhythmia during real-time activity.
3. Electrophysiology Study (EPS): The gold standard. An invasive procedure where catheters are placed in the heart to map the electrical pathways. This confirms the diagnosis by inducing the tachycardia and identifying the presence of dual AV nodal pathways.

Laboratory Workup

While labs do not diagnose the arrhythmia, they are essential to rule out secondary causes:
* Thyroid Function Tests (TSH, Free T4): To rule out hyperthyroidism-induced tachycardia.
* Serum Electrolytes: Including potassium, magnesium, and calcium levels.
* Complete Blood Count (CBC): To rule out anemia, which can exacerbate cardiac workload.

5. Therapeutic Interventions

Management is divided into acute termination and long-term prevention.

Acute Termination (Vagal Maneuvers and Pharmacotherapy)

If the patient is hemodynamically stable, the first line of defense includes:
* Vagal Maneuvers: Valsalva maneuver, carotid sinus massage, or facial immersion in ice water. These increase parasympathetic tone, slowing AV node conduction.
* Adenosine: An intravenous bolus of adenosine is the gold standard for chemical cardioversion. It causes a transient AV block, successfully "breaking" the reentrant circuit.
* Calcium Channel Blockers/Beta-Blockers: Diltiazem or Verapamil can be used if adenosine is contraindicated.

Long-Term Management

• Catheter Ablation: This is the definitive treatment. Using radiofrequency energy or cryoablation, a cardiac electrophysiologist destroys the slow pathway. Success rates are typically >95%, and it is considered curative for most patients.
• Pharmacological Prophylaxis: In patients who decline or are not candidates for ablation, daily beta-blockers or non-dihydropyridine calcium channel blockers may be used to suppress episodes.
• Lifestyle Modifications: Reducing caffeine, alcohol, and managing stress levels.

6. Frequently Asked Questions (FAQ)

1. Is AVNRT a life-threatening heart condition?
In patients without structural heart disease, AVNRT is generally not life-threatening, though it is highly symptomatic and disruptive to daily life.

2. Can AVNRT be cured permanently?
Yes. Radiofrequency catheter ablation is considered a curative procedure with a very high success rate and low risk of recurrence.

3. What is the difference between AVNRT and Atrial Fibrillation?
AVNRT involves a specific, organized reentrant circuit in the AV node, whereas Atrial Fibrillation is characterized by chaotic, disorganized electrical activity in the atria.

4. How does the "frog sign" occur?
The frog sign is a rhythmic pulsation in the neck caused by the atria contracting against a closed tricuspid valve during the tachycardia, forcing blood back into the jugular veins.

5. Are there specific foods I should avoid?
While there is no "AVNRT diet," avoiding excessive caffeine, nicotine, and alcohol is recommended, as these substances act as stimulants that can trigger an episode.

6. What should I do if I feel an episode starting?
Remain calm, sit or lie down to prevent injury from falling, and perform a Valsalva maneuver (bearing down as if having a bowel movement) if you have been instructed to do so by your physician.

7. Can I exercise with AVNRT?
Generally, yes. However, if your episodes are frequent or triggered by exercise, you should consult an electrophysiologist before participating in high-intensity sports.

8. Is AVNRT hereditary?
AVNRT is not typically considered a genetic condition, though some individuals may be born with a predisposition to the dual-pathway physiology of the AV node.

9. How long does the ablation procedure take?
An elective catheter ablation for AVNRT typically takes between 1 to 3 hours, and most patients are discharged within 24 hours.

10. Do I need to be on blood thinners for AVNRT?
Unlike Atrial Fibrillation, AVNRT is usually an organized rhythm; therefore, long-term anticoagulation is rarely required unless there are other comorbidities like Atrial Fibrillation or high stroke risk factors.

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Please consult with a board-certified cardiologist or electrophysiologist for a personalized clinical assessment.

Related Clinical Integration

In the management of Atrioventricular Nodal Reentrant Tachycardia (AVNRT), clinical protocols prioritize rapid rhythm stabilization and long-term hemodynamic surveillance. Acute termination of the arrhythmia is typically achieved through the administration of Adenosine / أدينوسين 6mg/2ml, while patients requiring chronic rate control may be transitioned to Verapamil ER / فيراباميل ممتد المفعول (ER) 240mg. Throughout the diagnostic and therapeutic process, continuous assessment of cardiac rhythm is essential, necessitating the use of a Cardiac Monitor / جهاز مراقبة القلب (معدات طبية عامة) to ensure patient safety and detect potential recurrences. It is important to note that while radiofrequency energy is a cornerstone of electrophysiology, clinicians should distinguish these cardiac interventions from unrelated gastrointestinal procedures such as Barrett's Ablation - Radiofrequency Ablation (HALO) / استئصال مريء باريت - بالترددات الراديوية (HALO) (عملية صغرى في العيادة), which are indicated for esophageal pathology rather than cardiac arrhythmias.